Dachaigh › Lymphoma Cealla-B
Sgrùdaidhean clionaigeach Lymphoma Cealla-B a’ fastadh anns na SA
Tha 67 sgrùdaidhean airson Lymphoma Cealla-B a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- New York City, NY18 sgrùdaidhean
- Houston, TX16 sgrùdaidhean
- Chicago, IL13 sgrùdaidhean
- Nashville, TN11 sgrùdadh
- Philadelphia, PA11 sgrùdadh
- Rochester, MN10 sgrùdaidhean
- Milwaukee, WI9 sgrùdaidhean
- Baldwin Park, CA9 sgrùdaidhean
- Cleveland, OH9 sgrùdaidhean
- Boston, MA8 sgrùdaidhean
- Salt Lake City, UT8 sgrùdaidhean
- Washington, DC7 sgrùdaidhean
- Pittsburgh, PA7 sgrùdaidhean
- Columbus, OH7 sgrùdaidhean
- Charlotte, NC7 sgrùdaidhean
- Denver, CO7 sgrùdaidhean
- Seattle, WA7 sgrùdaidhean
- Dallas, TX7 sgrùdaidhean
- Aurora, CO7 sgrùdaidhean
- San Antonio, TX6 sgrùdaidhean
- New Haven, CT6 sgrùdaidhean
- Atlanta, GA6 sgrùdaidhean
- Los Angeles, CA6 sgrùdaidhean
- Edison, NJ6 sgrùdaidhean
- Mountain View, CA5 sgrùdaidhean
- Portland, OR5 sgrùdaidhean
- Ann Arbor, MI5 sgrùdaidhean
- St. Louis, MO5 sgrùdaidhean
- Kansas City, MO5 sgrùdaidhean
- Omaha, NE5 sgrùdaidhean
- Cincinnati, OH5 sgrùdaidhean
- Richmond, VA4 sgrùdaidhean
- Tampa, FL4 sgrùdaidhean
- Miami, FL4 sgrùdaidhean
- Louisville, KY4 sgrùdaidhean
- Winston-Salem, NC4 sgrùdaidhean
- Cedar Rapids, IA4 sgrùdaidhean
- Jacksonville, FL4 sgrùdaidhean
- Indianapolis, IN4 sgrùdaidhean
- Austin, TX3 sgrùdaidhean
Le stàit
- Arizona5 sgrùdaidhean
- California20 sgrùdaidhean
- Colorado12 sgrùdaidhean
- Connecticut6 sgrùdaidhean
- Florida15 sgrùdaidhean
- Georgia8 sgrùdaidhean
- Illinois13 sgrùdaidhean
- Indiana5 sgrùdaidhean
- Iowa6 sgrùdaidhean
- Kansas9 sgrùdaidhean
- Kentucky4 sgrùdaidhean
- Maryland7 sgrùdaidhean
- Massachusetts8 sgrùdaidhean
- Michigan7 sgrùdaidhean
- Minnesota12 sgrùdaidhean
- Missouri5 sgrùdaidhean
- Nebraska5 sgrùdaidhean
- New Jersey9 sgrùdaidhean
- New York20 sgrùdaidhean
- North Carolina11 sgrùdadh
- Ohio18 sgrùdaidhean
- Oregon6 sgrùdaidhean
- Pennsylvania16 sgrùdaidhean
- Sgìre Cholumbia3 sgrùdaidhean
- Tennessee13 sgrùdaidhean
- Texas26 sgrùdaidhean
- Utah8 sgrùdaidhean
- Virginia8 sgrùdaidhean
- Washington10 sgrùdaidhean
- Wisconsin10 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
A’ fastadhÌre 1
Aoisean 0 gu 18 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06173518Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
A’ fastadhSgrùdadh amharc
Aoisean 0 gu 38 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06131801T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06343311CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
A’ fastadhÌre 1/2
Aoisean 3 gu 39 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT05442515A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07439653A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06742996Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06350318Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
A’ fastadhÌre 2
Aoisean 60 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06052826A Study of Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell Lymphoma
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06213311A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07101328A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT05615636UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL
A’ fastadhÌre 1/2
31 Days – 30 Years · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT04544592Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT06526793A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT06634589Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT05272384Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07225439A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT06564038A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT06393738Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma
A’ fastadhSgrùdadh amharc
Aoisean 4 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT07652580Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 31 Lùna 2026 · NCT07516093A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT07123454Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT07520006A Study of ARC-02 in B-cell NHL
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT07691606Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT05826535Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
A’ fastadhÌre 1
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT05389423Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.